|
US4602035A
(en)
*
|
1983-12-07 |
1986-07-22 |
Hoechst-Roussel Pharmaceuticals Inc. |
Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines
|
|
GB8419963D0
(en)
*
|
1984-08-06 |
1984-09-12 |
Lundbeck & Co As H |
Intermediate compound and method
|
|
GB8814057D0
(en)
*
|
1988-06-14 |
1988-07-20 |
Lundbeck & Co As H |
New enantiomers & their isolation
|
|
PT759299E
(pt)
*
|
1995-08-16 |
2000-09-29 |
Lilly Co Eli |
Potenciacao da resposta de serotonina
|
|
KR100357975B1
(ko)
*
|
1997-07-08 |
2002-10-25 |
하. 룬트벡 아크티에 셀스카브 |
시탈로프램의 제조방법
|
|
UA62985C2
(en)
*
|
1997-11-10 |
2004-01-15 |
Lunnbeck As H |
A method for the preparation of citalopram
|
|
WO1998019512A2
(en)
*
|
1997-11-11 |
1998-05-14 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
|
DK1123284T3
(da)
|
1998-10-20 |
2003-04-28 |
Lundbeck & Co As H |
Fremgangsmåde til fremstilling af citalopram
|
|
AR021509A1
(es)
*
|
1998-12-08 |
2002-07-24 |
Lundbeck & Co As H |
Derivados de benzofurano, su preparacion y uso
|
|
KR20010081071A
(ko)
|
1998-12-08 |
2001-08-25 |
피터슨 존 메이달 |
벤조푸란 유도체, 그것들의 제조 및 사용
|
|
JP2002533450A
(ja)
|
1998-12-23 |
2002-10-08 |
ハー・ルンドベック・アクチエゼルスカベット |
５−シアノフタリドの製造方法
|
|
AR022329A1
(es)
|
1999-01-29 |
2002-09-04 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-cianoftalida
|
|
CN1142926C
(zh)
*
|
1999-04-14 |
2004-03-24 |
H·隆德贝克有限公司 |
制备西酞普兰的方法
|
|
ITMI991581A1
(it)
*
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
|
ITMI991579A1
(it)
*
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
|
ITMI991486A1
(it)
*
|
1999-07-06 |
2001-01-06 |
Vis Farmaceutici S P A |
Processo per la sintesi di citalopram
|
|
AR021155A1
(es)
*
|
1999-07-08 |
2002-06-12 |
Lundbeck & Co As H |
Tratamiento de desordenes neuroticos
|
|
PT1228056E
(pt)
|
1999-10-25 |
2005-02-28 |
Lundbeck & Co As H |
Metodo de preparacao de citaloprame
|
|
TR200101874T1
(tr)
|
1999-10-25 |
2002-02-21 |
H. Lundbeck A/S |
Sitalopram hazırlanması için yöntem
|
|
US6310222B1
(en)
*
|
1999-11-01 |
2001-10-30 |
Sumika Fine Chemicals Co., Ltd. |
Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
|
|
AR026063A1
(es)
|
1999-11-01 |
2002-12-26 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-carboxiftalida.
|
|
JP2003519136A
(ja)
*
|
1999-12-28 |
2003-06-17 |
ハー・ルンドベック・アクチエゼルスカベット |
シタロプラムの製造方法
|
|
PT1246813E
(pt)
*
|
1999-12-30 |
2004-02-27 |
Lundbeck & Co As H |
Metodo para a preparacao de citalopram
|
|
PL197821B1
(pl)
*
|
2000-01-14 |
2008-04-30 |
Lundbeck & Co As H |
Sposób wytwarzania 5-cyjanoftalidu
|
|
US6433196B1
(en)
*
|
2000-02-17 |
2002-08-13 |
Sumika Fine Chemicals Co., Ltd. |
Production method of citalopram, intermediate therefor and production method of the intermediate
|
|
IES20010143A2
(en)
*
|
2000-02-24 |
2001-07-25 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
|
NL1017415C1
(nl)
*
|
2000-02-24 |
2001-05-18 |
Lundbeck & Co As H |
Werkwijze voor de bereiding van Citalopram.
|
|
IES20010157A2
(en)
*
|
2000-03-03 |
2002-03-06 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
|
GB0005477D0
(en)
|
2000-03-07 |
2000-04-26 |
Resolution Chemicals Limited |
Process for the preparation of citalopram
|
|
NL1017500C1
(nl)
|
2000-03-13 |
2001-04-26 |
Lundbeck & Co As H |
Werkwijze voor de bereiding van Citalopram.
|
|
GB2357762B
(en)
*
|
2000-03-13 |
2002-01-30 |
Lundbeck & Co As H |
Crystalline base of citalopram
|
|
MXPA02008684A
(es)
*
|
2000-03-13 |
2003-02-24 |
Lundbeck & Co As H |
Alquilacion gradual de 1-(4-fluorofenil)-1,3-dihidroisobenzofuranos 5-substituidos.
|
|
PL360110A1
(en)
*
|
2000-03-13 |
2004-09-06 |
H.Lundbeck A/S |
Method for the preparation of citalopram
|
|
EP1265882B1
(en)
|
2000-03-14 |
2004-01-14 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
|
ES2159271B1
(es)
*
|
2000-03-16 |
2002-05-01 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-ciano-1-(4-fluorofenil)-1,3-dihidroisobenzofuranos
|
|
AU5702201A
(en)
*
|
2000-04-13 |
2001-10-30 |
Mayo Foundation |
Abeta<sub>42</sub> lowering agents
|
|
US6977306B2
(en)
|
2000-05-02 |
2005-12-20 |
Sumitomo Chemical Company, Limited |
Citalopram hydrobromide crystal and method for crystallization thereof
|
|
AR032455A1
(es)
*
|
2000-05-12 |
2003-11-12 |
Lundbeck & Co As H |
Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
|
|
KR100821912B1
(ko)
*
|
2000-05-12 |
2008-04-16 |
하. 룬트벡 아크티에 셀스카브 |
시탈로프람의 제조 방법
|
|
AU2001272368A1
(en)
*
|
2000-07-06 |
2002-01-21 |
H. Lundbeck, A/S |
Method for the preparation of citalopram
|
|
EA005621B1
(ru)
*
|
2000-07-21 |
2005-04-28 |
Х.Лундбекк А/С |
Гетероциклические соединения в качестве ингибиторов транспортера глицина
|
|
IS6021A
(is)
*
|
2000-08-10 |
2001-10-20 |
H. Lundbeck A/S |
Lyfjasamsetningar sem innihalda sítalópram
|
|
CA2354877C
(en)
*
|
2000-08-18 |
2006-05-02 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
|
US20030109577A1
(en)
*
|
2000-10-27 |
2003-06-12 |
Ken Liljegren |
Pharmaceutical composition containing citalopram
|
|
US20030232881A1
(en)
*
|
2000-10-27 |
2003-12-18 |
H. Lundbeck A/S |
Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
|
|
IT1319686B1
(it)
*
|
2000-12-12 |
2003-10-23 |
C D Farmasint S R L |
Procedimento di preparazione di citalopram.
|
|
EP1181713B1
(en)
|
2000-12-22 |
2004-09-29 |
H. Lundbeck A/S |
Method for the preparation of pure citalopram
|
|
DE10164725B4
(de)
*
|
2000-12-28 |
2004-08-26 |
H. Lundbeck A/S |
Verfahren zur Herstellung von gereinigtem Citalopram
|
|
DE60100016T2
(de)
*
|
2000-12-28 |
2003-04-17 |
H. Lundbeck A/S, Valby |
Verfahren zur herstellung von reinem citalopram
|
|
DE10112828C1
(de)
*
|
2000-12-28 |
2002-11-21 |
Lundbeck & Co As H |
Verfahren zur Herstellung von Citalopram
|
|
AU2001100195B4
(en)
*
|
2001-01-05 |
2001-12-20 |
H Lundbeck As |
Pharmaceutical composition containing citalopram.
|
|
WO2002060886A1
(en)
|
2001-01-30 |
2002-08-08 |
Orion Corporation, Fermion |
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
|
|
US20040133017A1
(en)
*
|
2001-02-22 |
2004-07-08 |
Pulla Reddy Muddasani |
Process for the preparation of citalopram
|
|
GB0105627D0
(en)
*
|
2001-03-07 |
2001-04-25 |
Cipla Ltd |
Preparation of phthalanes
|
|
RU2003130073A
(ru)
*
|
2001-03-09 |
2005-04-10 |
Ранбакси Лабораторис Лимитед (In) |
Способ получения циталопрама
|
|
WO2002087566A1
(en)
*
|
2001-05-01 |
2002-11-07 |
H. Lundbeck A/S |
The use of enantiomeric pure escitalopram
|
|
BG65271B1
(bg)
*
|
2001-06-18 |
2007-11-30 |
H. Lundbeck A/S |
Метод за получаване на циталопрам
|
|
AR034759A1
(es)
*
|
2001-07-13 |
2004-03-17 |
Lundbeck & Co As H |
Metodo para la preparacion de escitalopram
|
|
IN192057B
(no)
*
|
2001-07-19 |
2004-02-14 |
Ranbaxy Lab Ltd |
|
|
ATE286730T1
(de)
*
|
2001-07-31 |
2005-01-15 |
Lundbeck & Co As H |
Kristalline zusammensetzung mit escitalopram
|
|
EP1288211A1
(en)
*
|
2001-08-28 |
2003-03-05 |
Sekhsaria Chemicals Ltd. |
Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
|
US6967259B2
(en)
*
|
2001-09-24 |
2005-11-22 |
Pharmachem Technologies Limited |
Process for the preparation of Citalopram intermediate
|
|
EP1434763B1
(en)
*
|
2001-10-12 |
2018-01-17 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl vasopressin v1a antagonists
|
|
IN192863B
(no)
*
|
2001-11-13 |
2004-05-22 |
Ranbaxy Lab Ltd |
|
|
IS7239A
(is)
*
|
2001-12-14 |
2004-04-29 |
H. Lundbeck A/S |
Aðferð til framleiðslu á essítalóprami
|
|
WO2003057132A2
(en)
*
|
2002-01-07 |
2003-07-17 |
Sun Pharmaceutical Industries Limited |
Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
|
|
GB0204607D0
(en)
*
|
2002-02-27 |
2002-04-10 |
Matrix Lab Ltd |
Process
|
|
GB2385848A
(en)
*
|
2002-02-27 |
2003-09-03 |
Cipla Ltd |
Citalopram salts
|
|
GB2387596B
(en)
*
|
2002-02-27 |
2004-02-11 |
Matrix Lab Ltd |
Process
|
|
EP1346989A1
(en)
*
|
2002-03-21 |
2003-09-24 |
Jubilant Organosys Limited |
Improved process for the preparation of citalopram and its hydrobromide
|
|
DE60334785D1
(de)
*
|
2002-03-27 |
2010-12-16 |
Bando Chemical Ind |
Neues 1,3,5-tris(arylamino)benzol
|
|
CA2381341A1
(en)
*
|
2002-04-09 |
2003-10-09 |
Torcan Chemical Ltd. |
Process and intermediates for preparing escitalopram
|
|
FI20021421A0
(fi)
*
|
2002-07-30 |
2002-07-30 |
Orion Corp Fermion |
Valmistusmenetelmä
|
|
PE20040991A1
(es)
|
2002-08-12 |
2004-12-27 |
Lundbeck & Co As H |
Separacion de intermediarios para la preparacion de escitalopram
|
|
AU2002330730A1
(en)
*
|
2002-08-14 |
2004-03-03 |
Natco Pharma Limited |
Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
|
|
GB2385051B
(en)
*
|
2002-08-29 |
2003-12-24 |
Max India Ltd |
Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans
|
|
US6812355B2
(en)
|
2002-10-22 |
2004-11-02 |
Sekhsaria Chemicals Limited |
Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
|
BR0317623A
(pt)
*
|
2002-12-23 |
2005-11-29 |
Lundbeck & Co As H |
Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
|
|
US20050137255A1
(en)
*
|
2002-12-23 |
2005-06-23 |
H. Lundbeck A/S |
Crystalline escitalopram hydrobromide and methods for preparing the same
|
|
AU2003242990A1
(en)
*
|
2003-01-17 |
2004-08-13 |
Pulla Reddy Muddasani |
Processes for the preparation of escitalopram and its precursor
|
|
EP1603548A4
(en)
*
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
|
|
ITMI20030479A1
(it)
*
|
2003-03-13 |
2004-09-14 |
Adorkem Technology S P A |
Procedimento per la preparazione di un ciano-isobenzofurano.
|
|
US7019153B2
(en)
*
|
2003-06-10 |
2006-03-28 |
Sun Pharmaceutical Industries Limited |
Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
|
|
US20050042284A1
(en)
*
|
2003-07-11 |
2005-02-24 |
Myriad Genetics, Incorporated |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
|
|
GB0317475D0
(en)
*
|
2003-07-25 |
2003-08-27 |
Meditab Specialities Pvt Ltd |
Product
|
|
ITFI20030202A1
(it)
*
|
2003-07-28 |
2005-01-29 |
Synteco Spa |
Processo per la preparazione di derivati del
|
|
US7402680B2
(en)
*
|
2003-09-17 |
2008-07-22 |
Janssen Pharmaceutica, N.V. |
Fused heterocyclic compounds
|
|
ATE293106T1
(de)
*
|
2003-10-28 |
2005-04-15 |
Adorkem Technology Spa |
Verfahren zur herstellung von citalopram
|
|
BR0318581A
(pt)
*
|
2003-10-28 |
2006-10-10 |
Wockhardt Ltd |
processo melhorando para fabriacação de bromidrato de citalopram
|
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
WO2005053796A1
(en)
*
|
2003-12-02 |
2005-06-16 |
B & B Beheer Nv |
Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
|
|
JP5646126B2
(ja)
|
2003-12-11 |
2014-12-24 |
サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法
|
|
CN100569765C
(zh)
*
|
2003-12-19 |
2009-12-16 |
杭州民生药业集团有限公司 |
西酞普兰中间体晶体碱
|
|
TWI339651B
(en)
*
|
2004-02-12 |
2011-04-01 |
Lundbeck & Co As H |
Method for the separation of intermediates which may be used for the preparation of escitalopram
|
|
US20080119662A1
(en)
*
|
2004-02-16 |
2008-05-22 |
Jubilant Organosys Limted |
One Spot Synthesis of Citalopram from 5-Cyanophthalide
|
|
US20050196453A1
(en)
*
|
2004-03-05 |
2005-09-08 |
H. Lundbeck A/S |
Crystalline composition containing escitalopram
|
|
ITMI20040717A1
(it)
*
|
2004-04-09 |
2004-07-09 |
Adorkem Technology Spa |
Procedimento chemo-enzimatico per la preparazione dell'escitalopram
|
|
WO2006001877A2
(en)
*
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
CA2567249A1
(en)
*
|
2004-04-19 |
2006-10-05 |
Jds Pharmaceuticals, Llc |
Lithium combinations, and uses related thereto
|
|
EP1745180A1
(en)
*
|
2004-04-29 |
2007-01-24 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
|
CA2618985A1
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
US7989645B2
(en)
*
|
2004-08-23 |
2011-08-02 |
Sun Pharma Global Fze |
Process for preparation of citalopram and enantiomers
|
|
US7790935B2
(en)
|
2004-08-23 |
2010-09-07 |
Sun Pharma Global Fze |
Process for preparation of citalopram and enantiomers
|
|
JP2008534504A
(ja)
|
2005-03-22 |
2008-08-28 |
アゼヴァン ファーマスーティカルズ，インコーポレイテッド |
月経前障害を治療するためのβラクタミルアルカン酸
|
|
WO2006103550A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Ranbaxy Laboratories Limited |
Processes for the preparation of citalopram and its intermediate 5-aminophthalide
|
|
BRPI0610785A2
(pt)
*
|
2005-04-22 |
2016-09-13 |
Wyeth Corp |
polimorfo cristalino, processo para preparar o mesmo, forma cristalina, composição, e, métodos para tratar uma doença, distúrbios, e uma condição
|
|
GT200600164A
(es)
|
2005-04-22 |
2007-03-14 |
|
Derivados de dihidrobenzofuranos y usos de los mismos
|
|
PE20070093A1
(es)
*
|
2005-04-22 |
2007-02-07 |
Wyeth Corp |
Derivados dihidrobenzofuranos como moduladores del receptor 5-ht2c
|
|
AU2006239922A1
(en)
*
|
2005-04-22 |
2006-11-02 |
Wyeth |
Benzofuranyl alkanamine derivatives and uses thereof as 5-HT2c agonists
|
|
US7834201B2
(en)
|
2005-06-22 |
2010-11-16 |
H. Lundbeck A/S |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
|
TWI347942B
(en)
|
2005-06-22 |
2011-09-01 |
Lundbeck & Co As H |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
|
US20070015138A1
(en)
*
|
2005-07-08 |
2007-01-18 |
Braincells, Inc. |
Methods for identifying agents and conditions that modulate neurogenesis
|
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
|
CN101268068B
(zh)
*
|
2005-07-19 |
2015-12-02 |
阿泽范药品公司 |
β-内酰胺基苯丙氨酸、半胱氨酸和丝氨酸血管加压素拮抗剂
|
|
US20070042034A1
(en)
*
|
2005-07-22 |
2007-02-22 |
Myriad Genetics, Incorporated |
High drug load formulations and dosage forms
|
|
US7598255B2
(en)
|
2005-08-04 |
2009-10-06 |
Janssen Pharmaceutica Nv |
Pyrimidine compounds as serotonin receptor modulators
|
|
CA2625153A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
CA2625210A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
WO2007054105A2
(en)
*
|
2005-11-14 |
2007-05-18 |
H. Lundbeck A/S |
Method for the preparation of escitalopram
|
|
GB0601286D0
(en)
|
2006-01-23 |
2006-03-01 |
Sandoz Ag |
Asymmetric synthesis
|
|
FR2912057B1
(fr)
*
|
2007-02-07 |
2009-04-17 |
Sanofi Aventis Sa |
Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
|
|
CA2643199A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20100216734A1
(en)
*
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
MX2008012094A
(es)
*
|
2006-03-24 |
2008-10-03 |
Wyeth Corp |
Nuevas combinaciones terapeuticas para el tratamiento de la depresion.
|
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
JP2009536669A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス，インコーポレイティド |
アンジオテンシン調節による神経新生
|
|
US7678808B2
(en)
|
2006-05-09 |
2010-03-16 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
|
US7858611B2
(en)
*
|
2006-05-09 |
2010-12-28 |
Braincells Inc. |
Neurogenesis by modulating angiotensin
|
|
US20080033045A1
(en)
*
|
2006-07-07 |
2008-02-07 |
Myriad Genetics, Incorporated |
Treatment of psychiatric disorders
|
|
TW200817003A
(en)
*
|
2006-07-31 |
2008-04-16 |
Sanofi Aventis |
Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
|
|
WO2008059514A2
(en)
*
|
2006-07-31 |
2008-05-22 |
Cadila Healthcare Limited |
Process for preparing escitalopram
|
|
AU2007292848A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100016274A1
(en)
*
|
2006-09-14 |
2010-01-21 |
Koppel Gary A |
Beta-lactam cannabinoid receptor modulators
|
|
AU2007299920A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
JP4927497B2
(ja)
*
|
2006-10-25 |
2012-05-09 |
株式会社シスコ |
無湿乾燥用ホッパー装置
|
|
CN100457747C
(zh)
*
|
2006-11-21 |
2009-02-04 |
浙江大学 |
抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺
|
|
US20080167363A1
(en)
*
|
2006-12-28 |
2008-07-10 |
Braincells, Inc |
Modulation of Neurogenesis By Melatoninergic Agents
|
|
AU2008204800A1
(en)
*
|
2007-01-11 |
2008-07-17 |
Braincells, Inc. |
Modulation of neurogenesis with use of modafinil
|
|
US7566793B2
(en)
*
|
2007-04-23 |
2009-07-28 |
Synthon Bv |
Process for resolving citalopram
|
|
EP2155710A2
(en)
*
|
2007-05-18 |
2010-02-24 |
Cipla Limited |
Process for the preparation of escitalopram via desmethylcitalopram, optical resolution and methylation of the s-isomer
|
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
|
EP2017271A1
(en)
|
2007-07-06 |
2009-01-21 |
Aurobindo Pharma Limited |
Process for the preparation of escitalopram
|
|
US8022232B2
(en)
*
|
2007-09-11 |
2011-09-20 |
H. Lundbeck A/S |
Method for manufacture of escitalopram
|
|
KR101103118B1
(ko)
*
|
2007-11-02 |
2012-01-04 |
동아제약주식회사 |
신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
|
|
US20110034565A1
(en)
|
2008-04-18 |
2011-02-10 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
EP2116231A1
(en)
|
2008-05-07 |
2009-11-11 |
Hexal Ag |
Granulate comprising escitalopram oxalate
|
|
US20100087664A1
(en)
*
|
2008-10-07 |
2010-04-08 |
Ravindra Vedantham |
Preparation of citalopram and salts thereof
|
|
GR20080100696A
(el)
|
2008-10-23 |
2010-05-13 |
Genepharm �.�. |
Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
US8653263B2
(en)
|
2009-10-23 |
2014-02-18 |
Janssen Pharmaceutica |
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
|
|
ES2662350T3
(es)
|
2010-07-01 |
2018-04-06 |
Azevan Pharmaceuticals, Inc. |
Procedimientos para el tratamiento del trastorno por estrés postraumático
|
|
WO2013081567A1
(en)
|
2011-12-02 |
2013-06-06 |
Mahmut Bilgic |
Effervescent antipsychotic formulations
|
|
WO2013100870A1
(en)
|
2011-12-02 |
2013-07-04 |
Mahmut Bilgic |
New antipsychotic compositions
|
|
WO2013110313A1
(en)
*
|
2012-01-23 |
2013-08-01 |
H. Lundbeck A/S |
Selective allosteric modulators of the serotonin transporter
|
|
KR20160130853A
(ko)
|
2014-03-28 |
2016-11-14 |
아제반 파마슈티칼스, 인코퍼레이티드 |
신경변성 질환을 치료하기 조성물 및 방법
|
|
BR112018067906A2
(pt)
|
2016-03-10 |
2019-01-29 |
Janssen Pharmaceutica Nv |
métodos de tratamento de depressão usando antagonistas do receptor de orexina-2
|
|
AU2018333051B2
(en)
|
2017-09-15 |
2024-03-21 |
Azevan Pharmaceuticals, Inc. |
Compositions and methods for treating brain injury
|
|
JP7739256B2
(ja)
|
2019-07-19 |
2025-09-16 |
バイオエクセル セラピューティクス，インコーポレイテッド |
鎮静作用のないデクスメデトミジン治療レジメン
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|